EURETINA 2020: Benefits of Intravitreal Aflibercept For Neovascular Age-Related Macular Degeneration Confirmed in Real-World Study
RAINBOW study demonstrated best outcomes with three initial monthly injections, followed by continuous proactive treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.